COMP <GO>

CHE vs JNJ // RSI-14 & 200D SMA MOMENTUM

Chemed Corp (NYSE) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: CHE 5 — JNJ 7

▲ RSI-14 & 200D SMA MOMENTUM LEADER: CHE

LAST: $534.72 (-1.33%) • MKT CAP: $7.08B

rsi-technicals

61.8

LAST: $273.20 (-0.73%) • MKT CAP: $662.49B

rsi-technicals

60.4

15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CHE VS. JNJ) EMERALD CELL = QUANTITATIVE EDGE

INSTITUTIONAL METRIC	CHE	JNJ	SPREAD (A - B)	ADVANTAGE	DEDICATED URL
Gross Profit Margin	32.50%	67.90%	-35.40	JNJ	/gross-margins <GO>
Return on Invested Capital (ROIC)	23.40%	25.50%	-2.10	JNJ	/roic <GO>
EV/EBITDA & P/E Valuation	18.5x	18.5x	0.00	TIE	/valuation <GO>
Free Cash Flow Yield	4.60%	2.97%	+1.63	CHE	/fcf-yield <GO>
Operating Margin	13.40%	34.70%	-21.30	JNJ	/operating-margins <GO>
Net Profit Margin	0.00%	28.50%	-28.50	JNJ	/net-margins <GO>
Revenue Growth (YoY)	65.30%	6.00%	+59.30	CHE	/revenue-growth <GO>
Dividend Yield & FCF Payout Safety	0.45%	0.00%	+0.45	CHE	/dividend-safety <GO>
Altman Z-Score & Debt/Equity	12.68	5.59	+7.09	CHE	/balance-sheet <GO>
Piotroski F-Score Quality	7/9	8/9	-1.00	JNJ	/piotroski-score <GO>
Options Implied Move & Put/Call Skew	7.20%	7.20%	0.00	TIE	/options-implied-move <GO>
RSI-14 & 200D SMA Momentum ACTIVE	61.8	60.4	+1.44	CHE	/rsi-technicals <GO>
10Y Yield & FRED Macro Beta	1.08	1.08	0.00	TIE	/macro-sensitivity <GO>
Forward P/E Multiple	140.0x	23.0x	+117.00	JNJ	/forward-pe <GO>
Enterprise Scale & Market Cap	$7.08B	$662.49B	-$655.41B	JNJ	/market-cap <GO>

5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY

FISCAL YEAR	CHE REV	JNJ REV	CHE GROSS %	JNJ GROSS %	CHE FCF	JNJ FCF
FY 2025	$2.53B	$94.19B	32.5%	67.9%	$325.5M	$19.70B
FY 2024	$1.53B	$88.82B	-3.0%	69.1%	$368.0M	$19.84B
FY 2023	$1.32B	$85.16B	44.0%	44.0%	$271.1M	$18.96B

FRED MACRO REGIME CORRELATION COMPARISON PEARSON r

CHE // BETA 1.08

JNJ // BETA 1.08